Literature DB >> 4015618

Cell proliferation-associated expression of a recently evolved isozyme of triosephosphate isomerase.

R S Decker, H W Mohrenweiser.   

Abstract

An electrophoretically unique, thermolabile isozyme of triosephosphate isomerase (TPI; EC 5.3.1.1) accounts for 10-30% of the enzymatic activity in a range of mitotically active human cells and tissues. This type 2 form (subunit) of human TPI appears in two isozymes, an anodally migrating, relative to the constitutive TPI-1/1 homodimer, TPI-2/2 homodimer and the TPI-1/2 heterodimer with an intermediate mobility. Human cell types expressing the induced isozyme, which is the product of the same structural locus as the constitutive isozyme, include mitogen-stimulated lymphocytes, virally transformed B-lymphoblastoid cells, leukemia-derived T-lymphoblastoid cells, HeLa cells, both normal and transformed fibroblasts, and placental tissue. Extracts of nondividing or terminally differentiated human cells/tissues, such as erythrocytes, striated muscle, peripheral lymphocytes, and platelets, contain high levels of the constitutive TPI-1/1 isozyme but little or undetectable levels of the TPI-1/2 or TPI-2/2 isozyme. The cell division-associated TPI-1/2 and -2/2 isozymes are distinct in electrophoretic mobility from the deamidated forms of the constitutive isozyme. Extracts of dividing gorilla fibroblasts display an isozyme pattern identical to that of proliferating human cells, but various proliferating cells derived from the African green monkey, rabbit, and chicken express only the constitutive isozyme. Thus, expression of the cell division-associated isozyme of TPI is restricted to the hominoids, suggesting a recently evolved modification mechanism which is specifically activated in proliferating cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4015618     DOI: 10.1007/bf00504324

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  36 in total

1.  The amino acid sequence of rabbit muscle triose phosphate isomerase.

Authors:  P H Corran; S G Waley
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

2.  Methods for starch-gel electrophoresis of sarcoplasmic proteins. An investigation of the relative mobilities of the glycolytic enzymes from the muscles of a variety of species.

Authors:  R K Scopes
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

3.  A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs.

Authors:  R A Young; O Hagenbüchle; U Schibler
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

4.  Alternative transcription and two modes of splicing results in two myosin light chains from one gene.

Authors:  Y Nabeshima; Y Fujii-Kuriyama; M Muramatsu; K Ogata
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

5.  Cotranslation of L and L' pyruvate kinase messenger RNAs from human fetal liver.

Authors:  J Marie; M P Simon; A Kahn
Journal:  Biochim Biophys Acta       Date:  1982-03-29

6.  A new isozyme of triose phosphate isomerase specific to hominoids.

Authors:  H Rubinson; M C Meienhofer; J C Dreyfus
Journal:  J Mol Evol       Date:  1973-11-27       Impact factor: 2.395

7.  Posttranslational modifications of enzymes.

Authors:  J C Dreyfus; A Kahn; F Schapira
Journal:  Curr Top Cell Regul       Date:  1978

8.  Evolution of alkaline phosphatases in primates.

Authors:  D J Goldstein; C Rogers; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Characterization of two new electrophoretic variants of human triosephosphate isomerase: stability, kinetic, and immunological properties.

Authors:  J Asakawa; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1982-02       Impact factor: 1.890

10.  Origin of the triosephosphate isomerase isozymes in humans: genetic evidence for the expression of a single structural locus.

Authors:  R S Decker; H W Mohrenweiser
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

View more
  7 in total

1.  Hominoid triosephosphate isomerase: regulation of expression of the proliferation specific isozyme.

Authors:  S E Old; L E Landa; H W Mohrenweiser
Journal:  Mol Cell Biochem       Date:  1989-08-15       Impact factor: 3.396

2.  Human triosephosphate isomerase: substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester.

Authors:  B A Perry; H W Mohrenweiser
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  Origin of human triosephosphate isomerase isozymes: further evidence for the single structural locus hypothesis with Japanese variants.

Authors:  J Asakawa; S Iida
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

4.  Hominoid triosephosphate isomerase: characterization of the major cell proliferation specific isozyme.

Authors:  R S Decker; H W Mohrenweiser
Journal:  Mol Cell Biochem       Date:  1986-06       Impact factor: 3.396

5.  Human triose-phosphate isomerase deficiency: a single amino acid substitution results in a thermolabile enzyme.

Authors:  I O Daar; P J Artymiuk; D C Phillips; L E Maquat
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancer.

Authors:  Sergio Enríquez-Flores; Luis A Flores-López; Ignacio De la Mora-De la Mora; Itzhel García-Torres; Isabel Gracia-Mora; Pedro Gutiérrez-Castrellón; Cynthia Fernández-Lainez; Yoalli Martínez-Pérez; Alberto Olaya-Vargas; Paul de Vos; Gabriel López-Velázquez
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

7.  Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target.

Authors:  Sergio Enríquez-Flores; Luis Antonio Flores-López; Itzhel García-Torres; Ignacio de la Mora-de la Mora; Nallely Cabrera; Pedro Gutiérrez-Castrellón; Yoalli Martínez-Pérez; Gabriel López-Velázquez
Journal:  Biomolecules       Date:  2020-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.